Research in Africa found a one-time dose of an experimental drug protected adults against malaria for at least six months, the latest approach in the fight against the mosquito-borne disease.
"The available vaccine doesn't protect enough people," said Dr. Kassoum Kayentao of the University of Sciences, Techniques and Technologies in Bamako, Mali, who helped lead the study in the villages of Kalifabougou and Torodo. The U.S. government research was published Monday in the New England Journal of Medicine and presented at a medical meeting in Seattle.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: